中国医院协会药事专业委员会临床药师培训进展研究

Clinical Pharmacist Training Progress of Pharmaceutical Affairs Committee of Chinese Hospital Association

  • 摘要:
    目的 了解我国临床药师的培训历程、现状与发展趋势。
    方法 分析中国医院协会药事专业委员会近5年(2019—2023年)发布的临床药师学员培训基地春秋季招生数据,包括培训人数、培训基地数量、专业种类等。
    结果 2023年临床药师培训计划招生人数为4106人,全国共设304家培训基地进行招生。开设了20个专科、1个通科及12个半年制专科,新增老年用药、全科医学、血液内科、精神科、急诊科5个专业。热门1年制专业包括抗感染、抗肿瘤、心血管内科、全科医学、呼吸内科、内分泌科专业。
    结论 我国临床药师培训规模持续扩大,培训人数、基地数量及专业种类相较于2019年均有明显涨幅,相关政策的颁布推动了培训进程,临床药师队伍不断壮大。

     

    Abstract:
    Objective To describe the history, current status and development trend of clinical pharmacist training in China.
    Methods The spring and autumn enrollment data of clinical pharmacists training base published by the Pharmaceutical Affairs Committee of Chinese Hospital Association in the past five years (2019—2023) were analyzed, including numbers of training personnel and training bases, types of professions, etc.
    Results In 2023, the enrollment of clinical pharmacist training plan was 4106, and 304 training bases were set up in China to enroll students. The Chinese Hospital Association set up 20 specialties, 1 general specialty and 12 half-year specialty specialties, and added 5 specialties of geriatric medicine, general medicine, hematology, psychiatry and emergency department. Popular one-year majors included anti-infection, anti-tumor, cardiovascular medicine, general medicine, respiratory medicine, and endocrinology.
    Conclusions The scale of clinical pharmacist training in China continues to expand, and the number of trainees, the number of hospitals in the training bases and the types of specialties have increased significantly compared with those in 2019. The promulgation of relevant policies has promoted the training process, and the team of clinical pharmacists has continued to grow.

     

/

返回文章
返回